CDT - Conduit Pharmaceuticals Inc. logo

Conduit Pharmaceuticals Inc.

CDT
Net income grew 100% of yearsRevenue grew 100% of years1Y
Compare CDT Hold
โš•๏ธ Healthcare NASDAQ Listed 2023 $ USD
$1,000 invested 1 year ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth+332.31%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth+78.99%
Rev TrendGrew
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth+172x
Net Trend33%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendEvery year
Revenue Consistencyโ€”

Explore the 2021 public Archive ranking โ†’

Where Conduit Pharmaceuticals Inc. has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CDT does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-20
$ 0.23โ€”
1 Year2025-11-20
$ 207.5K-100.00%
All Time2023-09-25
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

  • Revenue
  • Net Income
  • Cash
Year
TTM$ 4.85B$ 91M$ 348M
2025$ 2.71B-$ 39M$ 389M
2024$ 922M-$ 17M$ 554K
IPO2023$ 0.00-$ 535K$ 4M

Membership

Explore CDT with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,184 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies